AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biohit Oyj

Report Publication Announcement Mar 19, 2025

3304_rns_2025-03-19_ee11122b-13da-4f5f-bc6d-80a825f83d5b.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Publication of Biohit Oyj Annual Report 2024

Publication of Biohit Oyj Annual Report 2024

Biohit Oyj Annual Financial Report March 19, 2025 at 09:30 am local time (EET)

Biohit Oyj’s Annual Report 2024 is published today in PDF and XHTML format. The annual report contains financial statements for 2024, the Report of the Board of Directors and Corporate Governance Statements. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website:

Biohit (biohithealthcare.com)

CEO Jussi Hahtela, Biohit Oyj

tel. +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Attachments:

Talk to a Data Expert

Have a question? We'll get back to you promptly.